| Characterization of the Intestinal and Vaginal Microbiota in Long-term Survivors of Gynecological Cancer (NCT05360459) | Maria Bailen Andrino | 2022-05-20 |
| Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies (NCT05051696) | Liu Zi | 2021-09-26 |
| Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer (NCT04807166) | Wenjun Cheng | 2021-08-24 |
| Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer (NCT04519151) | Sheba Medical Center | 2021-04-12 |
| Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial (NCT04679675) | Kaiser Permanente | 2020-11-20 |
| Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer (NCT04556071) | Xiaoxiang Chen | 2020-11-06 |
| Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer (NCT04566952) | Xiaoxiang Chen | 2020-10-28 |
| Limiting Chemotherapy Side Effects by Using Moxa (NCT02781155) | East and North Hertfordshire NHS Trust | 2016-02-01 |
| Effect of Early Compression and Exercise on Lymphedema Incidence in Patients With Gynecological Cancer (NCT02966327) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2015-06-01 |
| RT for Cervical Adenocarcinoma/adenosquamous Carcinoma (NCT06741046) | Peking Union Medical College Hospital | 2014-06-01 |
| A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer (NCT01654458) | Women's College Hospital | 2012-07-01 |
| Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin (NCT01074697) | Odense University Hospital | 2010-04-01 |
| Overcoming Obstacles to Clinical Trials Enrollment Through a Navigator Program (NCT01032447) | Stanford University | 2010-01-01 |
| Cognitive Behavioral Effects on Sleep, Pain, and Cytokines in Gynecologic Cancer (NCT02609880) | University of Florida | 2009-07-01 |
| A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies (NCT00523432) | University of Chicago | 2007-08-01 |
| A Trial for Patients With Advanced/Recurrent Endometrial Cancer (NCT00377520) | Eli Lilly and Company | 2006-09-01 |
| Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo (NCT00332280) | Auron Healthcare GmbH | 2006-05-01 |
| Questionnaire Study for Gynecological Cancer Survivors (NCT00391664) | U.S. Army Medical Research and Development Command | 2006-02-01 |
| Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies (NCT02182245) | Boehringer Ingelheim | 2005-10-01 |
| A Trial for Patients With Advanced/Recurrent Cervical Cancer (NCT00190983) | Eli Lilly and Company | 2005-02-01 |
| An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy (NCT00191646) | Eli Lilly and Company | 2002-10-01 |
| Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy (NCT00121030) | Amgen | 2002-10-01 |
| A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer. (NCT00191607) | Eli Lilly and Company | 2002-07-01 |